ASX:ALC

Alcidion Group (ALC) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.21 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALC stock logo

About Alcidion Group Stock (ASX:ALC)

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

ALC Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Alcidion Group Limited
Alcidion Group Ltd ALC
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Alcidion Group Ltd
When Should You Buy Alcidion Group Limited (ASX:ALC)?
See More Headlines
Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcidion Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
191
Year Founded
N/A

Profitability

Net Income
$-5,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$40.48 million
Book Value
A$0.07 per share

Miscellaneous

Outstanding Shares
1,340,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.35
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Ms. Kate Quirke
    MD, CEO & Executive Director
  • Mr. Matthew Gepp
    Chief Financial Officer
  • Ms. Julia Stevens
    Chief Operating Officer
  • Mr. Vivek Krishnan
    Chief Technology Officer
  • Kerstin Wahlqvist
    Investor Relations Manager
  • Ms. Maria Hunter
    Group General Counsel
  • Mr. Nick White
    Director of Marketing & Analytics
  • Ms. Tracey Harvey
    Human Resources Manager
  • Ms. Amanda James
    Chief People Officer
  • Mr. Paul Deffley
    UK Chief Medical Officer

ALC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Alcidion Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcidion Group investors own include Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Immunomedics (IMMU), NAOS Emerging Opportunities (NCC), Novartis (NVS), Teck Resources (TECK), Ability (ABIL), AbbVie (ABBV) and

This page (ASX:ALC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners